Tag: Pharmaceutical industry

Key Cancer Drug by AstraZeneca and Daiichi Sankyo Receives First U.S. ApprovalIn a groundbreaking development in the fight against breast cancer, a cutting-edge chemotherapy treatment developed by AstraZeneca and Daiichi Sankyo has been granted...

**Optimizing Online Marketing Strategies for GLP-1 Compounded Drugs: Balancing Benefits and Risks**In Connecticut, the landscape of healthcare is undergoing a transformation as Medicaid tightens its grip on covering GLP-1 medications for obesity, leaving patients...

Lower-Priced Vials of Zepbound Drug Offer Hope for Patient AccessIn a groundbreaking move last year, Eli Lilly introduced lower-priced vials of its popular obesity drug, Zepbound, providing a glimmer of hope for patients struggling...

Lawmakers Urge FTC to Release Report on Pharmacy Benefit Managers A bipartisan, bicameral group of lawmakers has issued a call to the U.S. Federal Trade Commission (FTC) to release an interim staff report on pharmacy...

Eli Lilly Joins Lawsuit on Compounded DrugsIn a recent legal development, pharmaceutical giant Eli Lilly has made a significant move by seeking to join a lawsuit on compounded drugs. This decision comes after a...

Lilly CEO’s Big Payday and Olympics TreatIn the world of biotech, where science and politics intersect, there are always intriguing developments that capture the attention of industry insiders and the general public alike. Today,...

Novo Nordisk, a pharmaceutical giant, recently experienced a setback that sent shockwaves through the industry. The company's highly anticipated next-generation obesity drug, CagriSema, failed to meet investors' expectations, resulting in a significant drop in...

A U.K. trade group is preparing to lift a two-year suspension of Novo Nordisk due to "serious breaches" in promoting an obesity drug. The suspension, which was issued on March 16, 2023, by the...

A legal setback for a compounding group has caused a decline in Hims stock, stirring up the biotech industry. The ruling against the Outsourcing Facility Association, a compounding trade group, has impacted the production...

Pfizer and GSK Make DEI Changes Amid Pharma Tariffs: A Look into Industry TransformationsAs another workweek comes to a close, the anticipation of weekend plans fills the air with promise. The prospect of catching...